BINV — BioInvent International AB Balance Sheet
0.000.00%
Last trade - 00:00- SEK1.76bn
- SEK975.69m
- SEK44.69m
- 30
- 10
- 33
- 11
Annual balance sheet for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 729 | 1,083 | 1,017 | 1,069 | 867 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 35.5 | 9.39 | 36.6 | 32.7 | 25.2 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 773 | 1,116 | 1,084 | 1,133 | 943 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 29.6 | 49.1 | 52 | 52.7 | 46 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 803 | 1,447 | 1,712 | 1,400 | 989 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 53.5 | 58.8 | 87.3 | 75.9 | 95.2 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 59.1 | 80.3 | 106 | 90.5 | 103 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 743 | 1,367 | 1,606 | 1,310 | 886 |
| Total Liabilities & Shareholders' Equity | 803 | 1,447 | 1,712 | 1,400 | 989 |
| Total Common Shares Outstanding |